Titan Bio-Tech share news, announcements and annual reports
BSE: 524717Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹360.45.
30 Oct: open ₹364.90, high ₹364.95, low ₹335.40
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,755 Cr1,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 51.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.67
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 49,199
Titan Bio-Tech share news and announcements
605 announcements, routine notices left out, newest first. Page 3 of 13.
Aug 2024
13 Aug · Management
13 Aug · Board meeting
5 Aug · Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015
5 Aug · Board meeting
Meeting on 13 Aug 2024: quarterly results
May 2024
29 May · Board meeting
29 May · Results
21 May · Board meeting
Meeting on 29 May 2024: audited results
Apr 2024
25 Apr · Management
17 Apr · Compliance Certificate Under Regulation 40
10 Apr · Compliance Certificate Under Reg. 7(3) Of SEBI(LODR) Regulation, 2015 For The F.Y Ended On 31St March, 2024
Feb 2024
12 Feb · Business
12 Feb · Results
Jan 2024
31 Jan · Board meeting
Meeting on 12 Feb 2024: quarterly results15 Jan · Legal
12 Jan · Legal
Exchange has sought clarification from Titan Biotech Ltd on January 11, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Nov 2023
Oct 2023
26 Oct · Board meeting
Meeting on 8 Nov 2023: quarterly results
Sep 2023
30 Sep · Meeting
29 Sep · Meeting
1 Sep · Management
1 Sep · Dividend
Aug 2023
10 Aug · Results
Jul 2023
31 Jul · Board meeting
Meeting on 10 Aug 2023: quarterly results
May 2023
15 May · Board meeting
Meeting on 29 May 2023: audited results and final dividend
Apr 2023
12 Apr · Management
Feb 2023
Jan 2023
27 Jan · Board meeting
Meeting on 4 Feb 2023: quarterly results
Nov 2022
14 Nov · Results
4 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
13 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 1 1